BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

Novartis decision completes a new model for SPCs in EU

17 April 2012

SCRIP Regulatory Affairs April 2012, 5
Authors: Mike Snodin and Michael Pears

This article appeared in the April 2012 edition of SCRIP Regulatory Affairs. It reports the decision in the Novartis v Actavis case at the CJEU (case C-442/11) and explains its significance and practical consequences.

Cookies & Privacy

We Use Cookies To Improve User Experience. If You Continue Without Changing Settings We Will Assume You Are Happy To Receive Cookies

Disable Cookies
Privacy & Cookies | Terms & Conditions